Jefferies upgrades Summit Therapeutics to Buy from Hold
Benzinga (via TradingView News) reports Jefferies raised its rating on Summit Therapeutics from Hold to Buy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.